title: Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis.
abstract: Patients with cystic fibrosis had a better acute bronchodilator response to albuterol and ipratropium bromide than to either drug alone. Further studies of long-term efficacy and safety seem justified.
authors.affiliation: Department of Pediatrics, University of Manitoba, Winnipeg, Canada.
authors.forename: I
authors.initials: I
authors.lastname: Sanchez
authors.forename: J
authors.initials: J
authors.lastname: Holbrow
authors.forename: V
authors.initials: V
authors.lastname: Chernick
mesh_terms: D000293:Adolescent; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage*; D001980:Bronchi / Q000187:drug effects*; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D008297:Male; D015656:Respiratory Mechanics
chemical_list: D009241:Ipratropium; D000420:Albuterol